Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)

NCT01147250 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

6068

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DRUG: Lixisenatide (AVE0010)
DRUG: Placebo

Sponsor

Sanofi